A detailed history of Stephens Consulting, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 2,300 shares of MDXG stock, worth $15,594. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,300
Previous 2,300 -0.0%
Holding current value
$15,594
Previous $20.2 Million 12.2%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$5.7 - $9.14 $2,280 - $3,656
-400 Reduced 14.81%
2,300 $20.2 Million
Q3 2023

Oct 25, 2023

SELL
$6.35 - $8.16 $6,350 - $8,160
-1,000 Reduced 27.03%
2,700 $19.7 Million
Q1 2022

Jan 19, 2023

SELL
$4.27 - $6.27 $853 - $1,254
-200 Reduced 5.13%
3,700 $17.4 Million
Q4 2021

Jan 19, 2023

BUY
$5.7 - $8.48 $22,230 - $33,072
3,900 New
3,900 $23.6 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $770M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Stephens Consulting, LLC Portfolio

Follow Stephens Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.